Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 >= 50%: Results from EMPOWER-Lung 1 study.


Gumus M., Chen C., Ivanescu C., Kilickap S., Bondarenko I., Ozguroglu M., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 39 Issue: 15
  • Publication Date: 2021
  • Doi Number: 10.1200/jco.2021.39.15_suppl.9078
  • Title of Journal : JOURNAL OF CLINICAL ONCOLOGY